stockportfolio.pro
GRAIL, Inc. (GRAL)
Healthcare · Diagnostics & Research · NasdaqGS
GRAIL, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $55.55M | $93.11M | $125.59M | $147.17M |
| Gross profit | $-116.45M | $-95.61M | $-78.02M | $-62.57M |
| Net income | $-5.40B | $-1.47B | $-2.03B | $-408.35M |
| Net margin | -9719.3% | -1574.2% | -1613.9% | -277.5% |
Source: GRAIL, Inc. SEC filings (10-K).
Explore 4 years of GRAIL, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track GRAL in your portfolio →
GRAIL, Inc. financial history by metric
About GRAIL, Inc.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
GRAIL, Inc. — frequently asked questions
What is GRAIL, Inc.'s revenue?
GRAIL, Inc. (GRAL) reported revenue of $147.17M for fiscal year 2025, up 17.2% from the prior year, according to its SEC filings.
Is GRAIL, Inc. profitable?
No — GRAL reported a net loss of $-408.35M in fiscal 2025.
What is GRAL's P/E ratio?
GRAIL, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is GRAIL, Inc. growing?
GRAL's revenue grew at roughly 38.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does GRAIL, Inc. have?
As of fiscal year 2025, GRAL carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is GRAIL, Inc.'s gross margin?
GRAL's gross margin was -42.5% in fiscal 2025 — gross profit of $-62.57M on revenue of $147.17M.
What is GRAIL, Inc.'s market cap?
GRAIL, Inc. (GRAL) has a market capitalization of about $2.62B, based on the latest data in our nightly-refreshed cache.
When does GRAIL, Inc.'s fiscal year end?
GRAL's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from GRAIL, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.